Projects per year
Personal profile
Education
- 1996 Dr.rer.nat., Institute of Pharmacy, University of Regensburg, Germany
- 1987 Master, Institute of Pharmacy, National Defense Medical Center
- 1985 Bachelor, School of Pharmacy, National Defense Medical Center
Experience
- 2019- Professor, Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University
- 2018- Professor, Master Program in Graduate Institute of Cancer Biology and Drug Discovery, Taipei Medical University
- 2018- Professor, Graduate Institute of Nanomedicine and Medical Engineering, Taipei Medical University
- 2016-2017 Professor,Ph.D. Program in Biotechnology Research and Development, Taipei Medical University.
- 2014-2018 Professor, Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University.
- 2013-2014 Professor, Department of Pharmaceutical Sciences, Taipei Medical University.
- 2013-2013 Professor, School of Pharmacy, Taipei Medical University.
- 2006-2007 Professor, Graduate Institute of Pharmacognosy, Taipei Medical University.
- 2002-2006 Associate Professor, Graduate Institute of Pharmacognosy, Taipei Medical University.
Awards
- Editorial Board:
- International Journal of Advanced Chemistry (IJAC)
- International Journal of Organic Chemistry
- Der Pharma Chemica
- Journal of Chemical Science and Technology
- Advances in Organic Chemistry (AOC)
- Journal of Bone Marrow and Stem Cell Research
- Journal of Natural Products Research Updates
- Innovational: Journal of Chemistry (IJChem)
- International Journal of Biological Instrumentation
- Asian Council of Science
- Editorial Advisory Board:
- The Open Cancer Journal (ISSN: 1874-0790)
- Recent Patent Reviews on Anti-cancer Drug Discovery
- Outstanding reviewer:
- Outstanding reviewer: Bioorganic & Medicinal Chemistry
- Outstanding reviewer: European Journal of Medicinal Chemistry
Research Interests
- New drugs discovery and development
- Medicinal chemistry
- Discovery of novel anticancer drugs
- Discovery of novel anti-inflammatory drugs
Related Link
Fingerprint
Dive into the research topics where Hsu-Shan Huang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Preclinical Development and Evaluation of Novel Nano-Engineered Multi-Target Small Molecule Inhibitor Nsc777205 for Metastatic Colorectal Cancer
8/1/22 → 7/31/23
Project: A - Government Institution › b - Ministry of Science and Technology
-
To Establish a Phenotypic Response Surface (Prs) Technology Platform to Optimize Combination Therapy for Cholangiocarcinoma.( II )
8/1/22 → 7/31/23
Project: A - Government Institution › b - Ministry of Science and Technology
-
標靶整合素αvβ3-FAK訊號網絡的膽管癌診療策略開發-以PRS技術平台優化膽管癌的組合療法(1/3)
8/1/21 → 7/31/22
Project: A - Government Institution › b - Ministry of Science and Technology
-
治療膠質母細胞瘤之新穎小分子多標靶抗癌藥物之設計合成與開發
8/1/20 → 7/1/21
Project: A - Government Institution › b - Ministry of Science and Technology
-
New Development Strategy for Novel Multitarget Anticancer Drug Discovery through Artificial Intelligence (Ai) and Machine Learning (Ml) Model
8/1/19 → 7/31/20
Project: A - Government Institution › b - Ministry of Science and Technology
-
Anticancer Activities of 9-chloro-6-(piperazin-1-yl)-11H-indeno[1,2-c] quinolin-11-one (SJ10) in Glioblastoma Multiforme (GBM) Chemoradioresistant Cell Cycle-Related Oncogenic Signatures
Mokgautsi, N., Kuo, Y. C., Tang, S. L., Liu, F. C., Chen, S. J., Wu, A. T. H. & Huang, H. S., Jan 1 2022, In: Cancers. 14, 1, 262.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
Identification of a novel immune-inflammatory signature of COVID-19 infections, and evaluation of pharmacokinetics and therapeutic potential of RXn-02, a novel small-molecule derivative of quinolone
Lawal, B., Kuo, Y. C., Rachmawati Sumitra, M., Wu, A. T. H. & Huang, H. S., Sep 2022, In: Computers in Biology and Medicine. 148, 105814.Research output: Contribution to journal › Article › peer-review
Open Access2 Citations (Scopus) -
Leveraging Bulk and Single-Cell RNA Sequencing Data of NSCLC Tumor Microenvironment and Therapeutic Potential of NLOC-15A, A Novel Multi-Target Small Molecule
Lawal, B., Wu, A. T. H. & Huang, H. S., May 2022, In: Frontiers in Immunology. 13, 872470.Research output: Contribution to journal › Article › peer-review
Open Access4 Citations (Scopus) -
Liposome-encapsulated anthraquinone improves efficacy and safety in triple negative breast cancer
George, T. A., Chen, M. M., Czosseck, A., Chen, H. P., Huang, H. S. & Lundy, D. J., Feb 2022, In: Journal of Controlled Release. 342, p. 31-43 13 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Citations (Scopus) -
Luteolin-Rich Extract of Thespesia garckeana F. Hoffm. (Snot Apple) Contains Potential Drug-Like Candidates and Modulates Glycemic and Oxidoinflammatory Aberrations in Experimental Animals
Alozieuwa, U. B., Lawal, B., Sani, S., Onikanni, A. S., Osuji, O., Ibrahim, Y. O., Babalola, S. B., Mostafa-Hedeab, G., Alsayegh, A. A., Albogami, S., Batiha, G. E. S., Wu, A. T. H., Huang, H. S. & Conte-Junior, C. A., 2022, In: Oxidative Medicine and Cellular Longevity. 2022, 1215097.Research output: Contribution to journal › Article › peer-review
Open Access2 Citations (Scopus)
Datasets
-
CCDC 1417633: Experimental Crystal Structure Determination
Liu, F. (Creator), Chang, D. (Creator), Chen, C. (Creator), Chen, T. (Creator), Liu, F. (Creator), Ahmed Ali, A. A. (Contributor), Huang, H. (Creator) & Lee, C. (Creator), Cambridge Crystallographic Data Centre, 2015
DOI: 10.5517/cc1jl53d, https://doi.org/10.5517%2Fcc1jl53d
Dataset